SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-22-024218
Filing Date
2022-09-02
Accepted
2022-09-02 10:29:44
Documents
1
Period of Report
2022-09-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_166212897072850.html 4  
1 FORM 4 wf-form4_166212897072850.xml 4 3375
  Complete submission text file 0001628280-22-024218.txt   4880
Mailing Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098
Business Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Issuer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INCYTE CORPORATION, EXPERIMENTAL STN ROUTE 141 & HENRY CLAY ROAD, BLDG. E336 WILMINGTON DE 19880
Business Address
Huber Reid M (Reporting) CIK: 0001607052 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36783 | Film No.: 221223676